ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half

Go back to ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
Immucell Corp (NASDAQ: ICCC) Delayed: 9.99 -0.14 (1.38%)
Previous Close $10.13    52 Week High $8.29 
Open $10.10    52 Week Low $4.99 
Day High $10.10    P/E 124.88 
Day Low $9.81    EPS $0.08 
Volume 36,073